Samarth Kulkarni

Track

Insider profile

Currently holds a position at CRISPR Therapeutics AG

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 80% 68% 82%
Transactions
15 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Executive Officer, Director CRISPR Therapeutics AG May 30, 2018 -
Chief Executive Officer CRISPR Therapeutics AG Dec. 31, 2017 - May 30, 2018
President, Chief Business Officer CRISPR Therapeutics AG None -
Samarth Kulkarni's trades of CRISPR Therapeutics AG's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-24 2026-03-23
S Sale
82,616 -12.6%
380.31
US$4,361,506 		82,616 -12.6% 380.31 US$4,361,506
2026-03-17 2026-03-16
S Sale
65,132 +39.4%
137.01
US$3,479,102 		65,132 +39.4% 137.01 US$3,479,102
2026-03-12 2026-03-11
S Sale
81,964 +42.7%
372.80
US$2,315,143 		81,964 +42.7% 372.80 US$2,315,143
2026-02-20 2026-02-19
S Sale
6,967 -3.0%
52.58
US$366,325 		6,967 -3.0% 52.58 US$366,325
2026-01-22 2026-01-22
PrS Proposed sale
60,000
60.81
US$3,648,600 		60,000 60.81 US$3,648,600
2026-01-22 2026-01-22
PlS Planned sale
60,000 -30.9%
60.23
US$3,613,800 		60,000 -30.9% 60.23 US$3,613,800
2026-01-22 2026-01-20
PlS Planned sale
8,567 -4.2%
52.10
US$446,341 		8,567 -4.2% 52.10 US$446,341
2026-01-22 2026-01-20
PlS Planned sale
21,433 -9.6%
51.61
US$1,106,157 		21,433 -9.6% 51.61 US$1,106,157
2026-01-20 2026-01-20
PrS Proposed sale
30,000
52.61
US$1,578,300 		30,000 52.61 US$1,578,300
2025-10-20 2025-10-17
S Sale
50,895 -16.7%
67.91
US$3,456,279 		50,895 -16.7% 67.91 US$3,456,279
2025-10-15 2025-10-14
S Sale
4,242 -2.0%
66.60
US$282,517 		4,242 -2.0% 66.60 US$282,517
2025-08-19 2025-08-18
S Sale
13,081 -5.9%
58.15
US$760,660 		13,081 -5.9% 58.15 US$760,660
2025-03-24 2025-03-21
S Sale
10,031 -4.9%
41.23
US$413,578 		10,031 -4.9% 41.23 US$413,578
2025-03-12 2025-03-12
S Sale
4,462 -2.3%
43.32
US$193,294 		4,462 -2.3% 43.32 US$193,294
2025-03-12 2025-03-11
S Sale
9,973 -5.2%
42.42
US$423,055 		9,973 -5.2% 42.42 US$423,055
2025-02-21 2025-02-19
PlS Planned sale
18,360 -9.7%
55.21
US$1,013,564 		18,360 -9.7% 55.21 US$1,013,564
2025-02-19 2025-02-19
S Sale
6,928 -3.5%
52.80
US$365,798 		6,928 -3.5% 52.80 US$365,798
2025-02-19 2025-02-18
PlS Planned sale
11,640 -5.6%
55.05
US$640,782 		11,640 -5.6% 55.05 US$640,782
2025-02-18 2025-02-18
PrS Proposed sale
45,000
52.22
US$2,349,900 		45,000 52.22 US$2,349,900
2024-12-04 2024-12-02
PlS Planned sale
15,000 -7.6%
55.10
US$826,564 		15,000 -7.6% 55.10 US$826,564
2024-11-13 2024-11-11
PlS Planned sale
6,879 -3.4%
56.27
US$387,081 		6,879 -3.4% 56.27 US$387,081
2024-11-13 2024-11-11
PlS Planned sale
23,121 -10.2%
55.43
US$1,281,597 		23,121 -10.2% 55.43 US$1,281,597
2024-11-12 2024-11-11
PrS Proposed sale
75,000
54.86
US$4,114,500 		75,000 54.86 US$4,114,500
2024-10-15 2024-10-14
S Sale
4,293 -1.9%
46.28
US$198,680 		4,293 -1.9% 46.28 US$198,680
2024-04-17 2024-04-15
PlS Planned sale
1,204 -0.6%
60.40
US$72,722 		1,204 -0.6% 60.40 US$72,722
2024-04-17 2024-04-15
PlS Planned sale
18,378 -8.1%
59.88
US$1,100,510 		18,378 -8.1% 59.88 US$1,100,510
2024-04-15 2024-04-15
PrS Proposed sale
19,582
59.91
US$1,173,230 		19,582 59.91 US$1,173,230
2024-03-18 2024-03-15
PlS Planned sale
9,387 -4.3%
73.06
US$685,818 		9,387 -4.3% 73.06 US$685,818
2024-03-18 2024-03-15
PlS Planned sale
10,613 -4.7%
71.97
US$763,810 		10,613 -4.7% 71.97 US$763,810
2024-03-15 2024-03-15
PrS Proposed sale
20,000
72.48
US$1,449,628 		20,000 72.48 US$1,449,628
2024-03-12 2024-03-12
S Sale
4,583 -2.2%
74.44
US$341,159 		4,583 -2.2% 74.44 US$341,159
2024-03-12 2024-03-11
S Sale
9,802 -4.6%
78.26
US$767,105 		9,802 -4.6% 78.26 US$767,105
2024-02-21 2024-02-20
S Sale
6,370 -3.2%
79.67
US$507,498 		6,370 -3.2% 79.67 US$507,498
2024-02-16 2024-02-15
PlS Planned sale
1,100 -0.6%
81.66
US$89,831 		1,100 -0.6% 81.66 US$89,831
2024-02-16 2024-02-15
PlS Planned sale
5,951 -3.1%
81.04
US$482,257 		5,951 -3.1% 81.04 US$482,257
2024-02-16 2024-02-15
PlS Planned sale
12,949 -6.2%
79.94
US$1,035,090 		12,949 -6.2% 79.94 US$1,035,090
2024-02-15 2024-02-15
PrS Proposed sale
20,000
80.36
US$1,607,176 		20,000 80.36 US$1,607,176
2024-01-31 2024-01-29
PlS Planned sale
700 -0.4%
61.10
US$42,770 		700 -0.4% 61.10 US$42,770
2024-01-31 2024-01-29
PlS Planned sale
49,300 -20.8%
60.50
US$2,982,803 		49,300 -20.8% 60.50 US$2,982,803
2024-01-29 2024-01-29
PrS Proposed sale
50,000
60.51
US$3,025,570 		50,000 60.51 US$3,025,570
2024-01-18 2024-01-16
PlS Planned sale
20,000 -9.6%
62.50
US$1,250,058 		20,000 -9.6% 62.50 US$1,250,058
2024-01-16 2024-01-16
PrS Proposed sale
20,000
62.50
US$1,250,056 		20,000 62.50 US$1,250,056
2023-06-01 2023-05-30
PlS Planned sale
2,400 -0.6%
66.83
US$160,401 		2,400 -0.6% 66.83 US$160,401
2023-06-01 2023-05-30
PlS Planned sale
9,300 -2.3%
65.63
US$610,359 		9,300 -2.3% 65.63 US$610,359
2023-06-01 2023-05-30
PlS Planned sale
5,999 -1.5%
64.46
US$386,682 		5,999 -1.5% 64.46 US$386,682